The prevalence of VCA-IgM was found to be significantly higher in patients with lymphadenopathy than that in total of ≤30 year old non-NPC patients (χ2 = 9.59, P = 0.002). The gene discussed is CD40LG; the disease is nasopharyngeal carcinoma.